Biomea Fusion Statistics
Total Valuation
Biomea Fusion has a market cap or net worth of $60.45 million. The enterprise value is $26.50 million.
| Market Cap | 60.45M |
| Enterprise Value | 26.50M |
Important Dates
The next estimated earnings date is Tuesday, November 3, 2026, after market close.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Biomea Fusion has 72.48 million shares outstanding. The number of shares has increased by 84.48% in one year.
| Current Share Class | 72.48M |
| Shares Outstanding | 72.48M |
| Shares Change (YoY) | +84.48% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 6.64% |
| Owned by Institutions (%) | 40.72% |
| Float | 67.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 7.52 |
| P/TBV Ratio | 4.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.47, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.47 |
| Quick Ratio | 3.32 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -164.14% and return on invested capital (ROIC) is -146.76%.
| Return on Equity (ROE) | -164.14% |
| Return on Assets (ROA) | -63.46% |
| Return on Invested Capital (ROIC) | -146.76% |
| Return on Capital Employed (ROCE) | -211.67% |
| Weighted Average Cost of Capital (WACC) | 2.57% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$879,405 |
| Employee Count | 37 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.45% in the last 52 weeks. The beta is -0.30, so Biomea Fusion's price volatility has been lower than the market average.
| Beta (5Y) | -0.30 |
| 52-Week Price Change | -49.45% |
| 50-Day Moving Average | 1.50 |
| 200-Day Moving Average | 1.41 |
| Relative Strength Index (RSI) | 25.80 |
| Average Volume (20 Days) | 2,554,633 |
Short Selling Information
The latest short interest is 14.08 million, so 19.42% of the outstanding shares have been sold short.
| Short Interest | 14.08M |
| Short Previous Month | 13.22M |
| Short % of Shares Out | 19.42% |
| Short % of Float | 20.80% |
| Short Ratio (days to cover) | 6.26 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -55.86M |
| Pretax Income | -32.54M |
| Net Income | -32.54M |
| EBITDA | -55.32M |
| EBIT | -55.86M |
| Earnings Per Share (EPS) | -$0.47 |
Balance Sheet
The company has $34.82 million in cash and $877,000 in debt, with a net cash position of $33.95 million or $0.47 per share.
| Cash & Cash Equivalents | 34.82M |
| Total Debt | 877,000 |
| Net Cash | 33.95M |
| Net Cash Per Share | $0.47 |
| Equity (Book Value) | 12.14M |
| Book Value Per Share | 0.17 |
| Working Capital | 25.95M |
Cash Flow
| Operating Cash Flow | -47.19M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 540,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -47.19M |
| FCF Per Share | -$0.65 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Biomea Fusion does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -84.48% |
| Shareholder Yield | -84.48% |
| Earnings Yield | -53.96% |
| FCF Yield | -78.26% |
Analyst Forecast
The average price target for Biomea Fusion is $6.57, which is 687.77% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.57 |
| Price Target Difference | 687.77% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |